2020
DOI: 10.1007/978-981-15-6006-4_2
|View full text |Cite
|
Sign up to set email alerts
|

Advanced Biosensing Methodologies for Ultrasensitive Detection of Human Coronaviruses

Abstract: Rapid diagnosis of infectious diseases and up-to-the-minute commencement of relevant treatments are important factors that not only promote positive changes in the clinical scenario but also the health of the mass at large. Surpassing the time-consuming conventional, straightforward in vitro methods for diagnosing infectious diseases, biosensors have shown their tremendous potential in the recent era. Current developments concerning biosensing technologies bring point-of-care diagnostics to the forefront. This… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5
4
1

Relationship

3
7

Authors

Journals

citations
Cited by 13 publications
(6 citation statements)
references
References 83 publications
0
6
0
Order By: Relevance
“…In late 2019, the outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to the COVID-19 pandemic that has drastically impacted the human population, leaving the world clueless, and in an unimaginable situation. PCR, which detects the viral RNA, and serological screening by detecting antibodies generated in response to the infection, are the two primary screening procedures for confirming SARS-CoV-2 [ 125 , 126 , 127 , 128 ]. However, new methods are urgently needed due to the detection complexity, expense, and relatively longer analysis period of the present approaches.…”
Section: Label and Label-free Aptasensorsmentioning
confidence: 99%
“…In late 2019, the outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to the COVID-19 pandemic that has drastically impacted the human population, leaving the world clueless, and in an unimaginable situation. PCR, which detects the viral RNA, and serological screening by detecting antibodies generated in response to the infection, are the two primary screening procedures for confirming SARS-CoV-2 [ 125 , 126 , 127 , 128 ]. However, new methods are urgently needed due to the detection complexity, expense, and relatively longer analysis period of the present approaches.…”
Section: Label and Label-free Aptasensorsmentioning
confidence: 99%
“…Although there is a widespread use of spectroscopic and chromatographic techniques for small-molecule characterizations, sample clean-up, such as solid-phase extraction, is frequently required [ 86 ]. Sample preparation processes are laborious and require laboratory-based devices, costly, and time-consuming, limiting their utility [ 87 , 88 , 89 ].…”
Section: Small-molecule Detection Using Metallic Nanodendrite-based S...mentioning
confidence: 99%
“…50 ■ BIOSENSOR TECHNOLOGY FOR THE DETECTION OF SARS-COV-2 Standard Biosensors. Biosensors have been used to detect different types of viruses, including human coronavirus, 51 HIV, 52 hepatitis virus, 53 Zika virus, 54 and various influenza viruses. 55 Biosensor technology can also be applied for efficient and reliable detection of SARS-CoV-2 and its variants.…”
Section: T H I S C O N T E N T I S O N L Y L I C E N S E D F O R C O ...mentioning
confidence: 99%